Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 20.5.2019 | EN | Official Journal of the European Union | C 172/43 |

---

Action brought on 27 March 2019 — Aurea Biolabs v EUIPO — Avizel (AUREA BIOLABS)

(Case T-184/19)

(2019/C 172/57)

Language of the case: English

Parties

Applicant: Aurea Biolabs Pte Ltd (Cochin, India) (represented by: B. Brandreth, QC and L. Oommen, Solicitor)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Avizel SA (Luxembourg, Luxembourg)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for figurative mark AUREA BIOLABS — Application for registration No 15 836 737

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 29 January 2019 in Case R 814/2018-2 (CORR)

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order the payment of the Applicant’s costs. |

Pleas in law

|  |  |
| --- | --- |
| — | In support of its decision, the Board of Appeal relies on an invalid provision of law; |

|  |  |
| --- | --- |
| — | Had there been an obvious error of law, the appropriate course was to revoke the previous decision; |

|  |  |
| --- | --- |
| — | Infringement of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council and of the principles of natural justice. |

---

[Top](#document1)